Important pharmacy news and late-breaking industry information updated daily.
The new coronavirus, known as COVID-19, is causing fear around the world, and new cases in 12 U.S. states—89 cases as of 1:30 pm on March 2—mean that questions from patients will ramp up. A number of resources are available to help pharmacists separate fact from fiction, care for patients and communities, and stay prepared for whatever lies ahead.
There are new signs that the coronavirus was spreading undetected in some American communities for weeks.
Antibiotic stewardship programs (ASPs) must be implemented at all acute-care hospitals that participate in Medicare and Medicaid by March 30, 2020, according to a new CMS rule released late last year. This requirement will ensure that small and critical-access hospitals also adopt ASPs in an effort to promote appropriate antibiotic use.
The announcement on Wednesday that a woman in Northern California was infected with the coronavirus left health officials in California searching for people she may have exposed to the virus and testing the medical workers who have treated her.
A California individual who does not appear to have any relevant travel history or exposure to someone known to be infected with the new coronavirus has tested positive for COVID-19, CDC confirmed Wednesday. This could be the first case of community spread of the virus in the United States, according to the agency.
The new coronavirus, COVID-19, will almost definitely spread in the United States - and hospitals, businesses, and schools should start making plans.
On February 20, 2020, FDA published a final rule amending its definition of a “biological product.” The agency states that this action should make it easier to get cheaper biologics, such as insulin, on the market.
FDA on Monday approved the first generic of albuterol sulfate (ProAir HFA) inhalation aerosol. The approval, awarded to Perrigo Pharmaceutical Co., is for the treatment or prevention of bronchospasm in patients aged 4 years and older with reversible obstructive airway disease and the prevention of exercise-induced bronchospasm in patients aged 4...
FDA has approved bempedoic acid (Nexletol—Esperion Therapeutics), a new cholesterol medicine. Taken once a day, bempedoic acid is the first oral non-statin approved in nearly 20 years. The drug is viewed as an alternative for millions of patients who are unable to take or do not respond to statins.